IL279782B2 - Methods for producing recombinant proteins - Google Patents
Methods for producing recombinant proteinsInfo
- Publication number
- IL279782B2 IL279782B2 IL279782A IL27978220A IL279782B2 IL 279782 B2 IL279782 B2 IL 279782B2 IL 279782 A IL279782 A IL 279782A IL 27978220 A IL27978220 A IL 27978220A IL 279782 B2 IL279782 B2 IL 279782B2
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical composition
- polypeptide
- polyethylene glycol
- succinimidyl
- peg
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862693606P | 2018-07-03 | 2018-07-03 | |
| PCT/US2019/040298 WO2020010080A1 (en) | 2018-07-03 | 2019-07-02 | Methods of producing recombinant proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL279782A IL279782A (en) | 2021-03-01 |
| IL279782B1 IL279782B1 (en) | 2026-01-01 |
| IL279782B2 true IL279782B2 (en) | 2026-05-01 |
Family
ID=67470657
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL279782A IL279782B2 (en) | 2018-07-03 | 2019-07-02 | Methods for producing recombinant proteins |
| IL324666A IL324666A (en) | 2018-07-03 | 2019-07-02 | Methods of producing recombinant proteins |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL324666A IL324666A (en) | 2018-07-03 | 2019-07-02 | Methods of producing recombinant proteins |
Country Status (23)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL279782B2 (en) | 2018-07-03 | 2026-05-01 | Bristol Myers Squibb Co | Methods for producing recombinant proteins |
| EP4229174A1 (en) * | 2020-10-13 | 2023-08-23 | Boehringer Ingelheim International GmbH | Systems and methods for producing a biologic molecule with hydrocyclone cell retention device |
| DK181991B1 (en) * | 2021-11-11 | 2025-05-15 | Dsm Ip Assets Bv | Combined fermentation process for producing one or more human milk oligosaccharide(s) (hmo(s)) in escherichia coli |
| AU2023295808A1 (en) * | 2022-06-15 | 2025-01-30 | UCB Biopharma SRL | Cell culture processes |
| EP4339274B1 (en) | 2022-09-13 | 2025-03-26 | Sartorius Stedim Biotech GmbH | Method for operating a bioprocess installation for production of a bioproduct |
| KR20240172522A (ko) * | 2023-06-01 | 2024-12-10 | (주)알테오젠 | 지속형 호르몬 수용체 길항제의 생산 방법 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170107553A1 (en) * | 2014-06-03 | 2017-04-20 | Lupin Limited | Cell culture process for producing a protein |
| US20170114381A1 (en) * | 2014-06-04 | 2017-04-27 | Amgen Inc. | Methods for harvesting mammalian cell cultures |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4515893A (en) | 1979-04-26 | 1985-05-07 | Ortho Pharmaceutical Corporation | Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells |
| US5672347A (en) | 1984-07-05 | 1997-09-30 | Genentech, Inc. | Tumor necrosis factor antagonists and their use |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| US5091313A (en) | 1988-08-05 | 1992-02-25 | Tanox Biosystems, Inc. | Antigenic epitopes of IgE present on B cell but not basophil surface |
| US5720937A (en) | 1988-01-12 | 1998-02-24 | Genentech, Inc. | In vivo tumor detection assay |
| JP2749167B2 (ja) | 1988-06-21 | 1998-05-13 | ジェネンテク,インコーポレイテッド | 心筋梗塞の処置のための方法および治療用組成物 |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB2251249B (en) | 1990-12-28 | 1995-06-21 | Mogam Biotech Res Inst | High-density medium for animal cell culture |
| EP1260521B1 (en) | 1991-08-14 | 2007-11-21 | Genentech Inc. | Immunoglobulin variants for specific Fc epsilon receptors |
| CA2140933A1 (en) | 1992-08-21 | 1994-02-22 | Paula M. Jardieu | Method for treating an lfa-1 mediated disorder |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| EP0733207B1 (en) | 1993-12-10 | 1997-08-27 | Genentech, Inc. | Methods for diagnosis of allergy and screening of anti-allergy therapeutics |
| AP660A (en) | 1994-01-18 | 1998-08-18 | Genentech Inc | A method of treatment of parasitic infection using IgE antagonists. |
| US5707622A (en) | 1994-03-03 | 1998-01-13 | Genentech, Inc. | Methods for treating ulcerative colitis |
| IL117645A (en) | 1995-03-30 | 2005-08-31 | Genentech Inc | Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration |
| CA2222231A1 (en) | 1995-06-07 | 1996-12-19 | Imclone Systems Incorporated | Antibody and antibody fragments for inhibiting the growth of tumors |
| PT877626E (pt) | 1996-01-23 | 2003-01-31 | Univ Vermont And State Agric C | Anticorpos anti-cd1s para utilizacao contra icto |
| US7147851B1 (en) | 1996-08-15 | 2006-12-12 | Millennium Pharmaceuticals, Inc. | Humanized immunoglobulin reactive with α4β7 integrin |
| EP2221361A3 (en) | 1996-08-30 | 2011-02-09 | Life Technologies Corporation | Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium |
| AU731817C (en) | 1996-11-27 | 2001-11-01 | Genentech Inc. | Humanized anti-CD11a antibodies |
| DE69829891T2 (de) | 1997-04-07 | 2005-10-06 | Genentech, Inc., South San Francisco | Anti-VEGF Antikörper |
| PT981618E (pt) | 1997-05-15 | 2007-11-23 | Genentech Inc | ''anticorpo anti-apo-2'' |
| US5994511A (en) | 1997-07-02 | 1999-11-30 | Genentech, Inc. | Anti-IgE antibodies and methods of improving polypeptides |
| US6946129B1 (en) | 1999-06-08 | 2005-09-20 | Seattle Genetics, Inc. | Recombinant anti-CD40 antibody and uses thereof |
| KR100490077B1 (ko) | 1999-10-29 | 2005-05-17 | 제넨테크, 인크. | 항-전립선 줄기세포 항원 (psca) 항체 조성물 및 그의사용 방법 |
| US7294484B2 (en) | 2004-08-27 | 2007-11-13 | Wyeth Research Ireland Limited | Production of polypeptides |
| US7335491B2 (en) | 2004-08-27 | 2008-02-26 | Wyeth Research Ireland Limited | Production of anti-abeta |
| TW201516149A (zh) | 2006-09-13 | 2015-05-01 | Abbvie Inc | 細胞培養改良 |
| MX2009004974A (es) | 2006-11-08 | 2009-05-20 | Wyeth Corp | Medios diseñado racionalmente para cultivo celular. |
| WO2009023562A2 (en) | 2007-08-09 | 2009-02-19 | Wyeth | Use of perfusion to enhance production of fed-batch cell culture in bioreactors |
| DK2501822T3 (da) | 2009-11-17 | 2017-11-27 | Squibb & Sons Llc | Fremgangsmåder til forbedret proteinproduktion |
| LT2673296T (lt) | 2011-02-07 | 2019-02-25 | Cerenis Therapeutics Holding Sa | Lipoproteino kompleksai ir jų gamyba ir jų panaudojimai |
| WO2012149197A2 (en) | 2011-04-27 | 2012-11-01 | Abbott Laboratories | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| SI2726600T1 (sl) * | 2011-07-01 | 2017-07-31 | Amgen Inc. | Sesalska celična kultura |
| WO2015095809A1 (en) * | 2013-12-20 | 2015-06-25 | Biogen Idec Ma Inc. | Use of perfusion seed cultures to improve biopharmaceutical fed-batch production capacity and product quality |
| JP5731726B1 (ja) | 2014-06-26 | 2015-06-10 | 楽天株式会社 | 情報処理装置、情報処理方法及び情報処理プログラム |
| EP3420072B1 (en) | 2016-02-22 | 2025-06-18 | Agency for Science, Technology and Research | Cell culture medium |
| EP3440190B1 (en) | 2016-04-05 | 2024-08-28 | Pfizer Inc. | Cell culture process |
| WO2018039499A1 (en) | 2016-08-24 | 2018-03-01 | Regeneron Pharmaceuticals, Inc. | Host cell protein modification |
| IL279782B2 (en) | 2018-07-03 | 2026-05-01 | Bristol Myers Squibb Co | Methods for producing recombinant proteins |
-
2019
- 2019-07-02 IL IL279782A patent/IL279782B2/en unknown
- 2019-07-02 PT PT197458458T patent/PT3818078T/pt unknown
- 2019-07-02 CA CA3104684A patent/CA3104684A1/en active Pending
- 2019-07-02 CN CN201980044908.3A patent/CN112839954A/zh active Pending
- 2019-07-02 KR KR1020217003056A patent/KR102870511B1/ko active Active
- 2019-07-02 EA EA202092904A patent/EA202092904A1/ru unknown
- 2019-07-02 HR HRP20240584TT patent/HRP20240584T1/hr unknown
- 2019-07-02 EP EP24153543.4A patent/EP4368699A3/en active Pending
- 2019-07-02 US US17/252,163 patent/US12624336B2/en active Active
- 2019-07-02 SG SG11202012582QA patent/SG11202012582QA/en unknown
- 2019-07-02 DK DK19745845.8T patent/DK3818078T3/da active
- 2019-07-02 IL IL324666A patent/IL324666A/en unknown
- 2019-07-02 FI FIEP19745845.8T patent/FI3818078T3/fi active
- 2019-07-02 ES ES19745845T patent/ES2976708T3/es active Active
- 2019-07-02 LT LTEPPCT/US2019/040298T patent/LT3818078T/lt unknown
- 2019-07-02 PL PL19745845.8T patent/PL3818078T3/pl unknown
- 2019-07-02 JP JP2020573229A patent/JP7419273B2/ja active Active
- 2019-07-02 WO PCT/US2019/040298 patent/WO2020010080A1/en not_active Ceased
- 2019-07-02 AU AU2019299358A patent/AU2019299358B2/en active Active
- 2019-07-02 HU HUE19745845A patent/HUE066560T2/hu unknown
- 2019-07-02 KR KR1020257033442A patent/KR20250153311A/ko active Pending
- 2019-07-02 EP EP19745845.8A patent/EP3818078B1/en active Active
- 2019-07-02 SI SI201930722T patent/SI3818078T1/sl unknown
- 2019-07-02 RS RS20240475A patent/RS65472B1/sr unknown
- 2019-07-02 MX MX2020013633A patent/MX2020013633A/es unknown
- 2019-07-02 SM SM20240173T patent/SMT202400173T1/it unknown
-
2024
- 2024-01-10 JP JP2024001657A patent/JP2024050590A/ja active Pending
-
2025
- 2025-01-17 US US19/030,272 patent/US20250171732A1/en active Pending
- 2025-12-12 JP JP2025247705A patent/JP2026048825A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170107553A1 (en) * | 2014-06-03 | 2017-04-20 | Lupin Limited | Cell culture process for producing a protein |
| US20170114381A1 (en) * | 2014-06-04 | 2017-04-27 | Amgen Inc. | Methods for harvesting mammalian cell cultures |
Non-Patent Citations (4)
| Title |
|---|
| FRANKLIN LU ET AL,, AUTOMATED DYNAMIC FED-BATCH PROCESS AND MEDIA OPTIMIZATION FOR HIGH PRODUCTIVITY CELL CULTURE PROCESS DEVELOPMENT, 31 December 2013 (2013-12-31) * |
| POHLSCHEIDT MICHAEL ET AL,, OPTIMIZING CAPACITY UTILIZATION BY LARGE SCALE 3000 L PERFUSION IN SEED TRAIN BIOREACTORS, 31 December 2012 (2012-12-31) * |
| SEN XU ET AL,, BIOREACTOR PRODUCTIVITY AND MEDIA COST COMPARISON FOR DIFFERENT INTENSIFIED CELL CULTURE PROCESSES, 31 December 2017 (2017-12-31) * |
| YONGKY ANDREW ET AL,, BIOT 487: A NOVEL HIGH DENSITY N-1 BATCH SEED STRATEGY DEVELOPMENT FOR CHO CELL CULTURE MANUFACTURING, 31 December 2018 (2018-12-31) * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288205A (en) | Purification of fkpa and its uses for the production of recombinant polypeptides | |
| SG11202104136YA (en) | Heterodimeric fc-fused proteins | |
| SG11202012582QA (en) | Methods of producing recombinant proteins | |
| ZA202006604B (en) | Method for selection of high m6p recombinant proteins | |
| ZA201903356B (en) | Novel polypeptide and method of producing imp using the same | |
| IL286745A (en) | Continuous production of recombinant proteins | |
| GB201419109D0 (en) | Incorporation of unnatural amino acids into proteins | |
| ZA201902968B (en) | Method for increasing the secretion levels of interleukin 2 and proteins derived from it | |
| EP3236772A4 (en) | Methods of purifying recombinant proteins | |
| IL276067A (en) | Production of glucagon peptides | |
| IL284026A (en) | Methods of producing heterodimeric antibodies | |
| IL286475A (en) | Methods for the manufacture of recombinant viral vectors | |
| GB201806072D0 (en) | Methods of manufacture | |
| MA53498A (fr) | Production de protéines recombinantes | |
| ZA202101433B (en) | An improved process for the preparation of recombinant lectin protein | |
| IL262875B (en) | Methods of regulation of galactosylation profiles of recombinant proteins | |
| EP3377633C0 (en) | PRODUCTION OF RECOMBINANT PROTEINS | |
| IL262544A (en) | A method for producing a recombinant protein | |
| GB201805904D0 (en) | Methods of Manufacture | |
| EP3532618A4 (en) | SIGNAL POLYPEPTIDES FOR IMPROVED PROTEIN SECRETION | |
| SG11201708751RA (en) | Method of producing a recombinant protein | |
| IL314040B1 (en) | Methods for reducing trisulfide bonds during recombinant production of polypeptides | |
| EP3289092A4 (en) | Methods of manufacturing therapeutic proteins | |
| IL265297A (en) | Methods for regulating production profiles of recombinant proteins | |
| IL256706B (en) | A method for making recombinant proteins |